1.Stein, IF, Leventhal, ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181.
2.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 Jan;81(1):19–25.
3.Balen, AH, Laven, JS, Tan, SL, Dewailly, D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003 Nov–Dec;9(6):505–14.
4.Azziz, R, et al. for the Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006 Nov;91(11):4237–45.
5.Knochenhauer ES1, Key, TJ, Kahsar-Miller, M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998 Sep;83(9):3078–82.
6.Li, R, Zhang, Q, Yang, D, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 2013 Sep;28(9):2562–9.
7.Ezeh, U, Yildiz, BO, Azziz, R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metabol 2013 Jun;98(6):E1088–96.
8.Okoroh, EM, Hooper, WC, Atrash, HK, et al. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003–2008. Am J Obstet Gynecol 2012 Oct;207(4):299.e1–7.
9.Speroff, L, Fritz, MA. Clinical Gynecologic Endocrinology and Infertility, 7th edition. Philadelphia: Lippincott Williams & Wilkins, 2005; chapter 6, pp 187–231.
10.Speroff, L, Fritz, MA. Clinical Gynecologic Endocrinology and Infertility, 7th edition. Philadelphia: Lippincott Williams & Wilkins, 2005; chapter 12, pp 465–98.
11.Nestler, JE, Powers, LP, Matt, DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991 Jan;72(1):83–9.
12.Dunaif, A, Green, G, Futterweit, W, Dobrjansky, A. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1990 Mar;70(3):699–704.
13.ACOG. Practice Bulletin 108: polycystic ovary syndrome. October 2009.
14.Quinn, M, Shinkai, K, Pasch, L, et al. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertility Steril. 2014 Apr;101(4):1129–34.
15.Grundy, SM, Cleeman, JI, Daniels, SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 Oct 25;112(17):2735–52.
16.Ehrmann, DA, Liljenquist, DR, Kasza, K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006 Jan;91(1):48–53.
17.Karaca, Z, Acmaz, B, Acmaz, G, et al. Routine screening for Cushing’s syndrome is not required in patients presenting with hirsutism. Eur J Endocrinol 2013 Mar;168(3):379–84.
18.Yildiz, BO. Assessment, diagnosis and treatment of a patient with hirsutism. Nat Clin Pract Endoc 2008;4:294–300.
19.Wang, S, Alvero, R. Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. [Review] Semin Reprod Med 2013 Sep;31(5):365–9.
20.Clayton, RN, Ogden, V, Hodgkinson, J, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 1992 Aug;37(2):127–34.
21.Robinson, S, Rodin, DA, Deacon, A, et al. Which hormone tests for the diagnosis of polycystic ovary syndrome? Br J Obstet Gynaecol 1992 Mar;99(3):232–8.
22.Morgante, G, Musacchio, MC, Orvieto, R, et al. Alterations in thyroid function among the different polycystic ovary syndrome phenotypes. Gynecol Endocrinol 2013 Nov;29(11):967–9.
23.Eilertsen, TB, Vanky, E, Carlsen, SM. Anti-mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012 Aug;27(8):2494–502.
24.Celik, C, Tasdemir, N, Abali, R, et al. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study. Fertil Steril 2014 Apr;101(4):1123–8.
25.Legro, RS, Kunselman, AR, Dodson, WC, Dunaif, A, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999 Jan;84(1):165–9.
26.Shi, Y, Cui, Y, Sun, X, et al. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors. Eur J Obstet Gynecol Reprod Biol 2014 Feb;173:66–70.
27.Legro, RS, Kunselman, AR, Dunaif, A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001 Dec 1;111(8):607–13.
28.Mani, H, Levy, MJ, Davies, MJ, et al. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol 2013 Jun;78(6):926–34.
29.Guzick, DS, Talbott, EO, Sutton-Tyrrell, K, et al. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol 1996 Apr;174(4):1224–9.
30.Setji, TL, Holland, ND, Sanders, LL, et al. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006 May;91(5):1741–7.
31.Sahingoz, M, Uguz, F, Gezginc, K, Korucu, DG. Axis I and Axis II diagnoses in women with PCOS. Gen Hospit Psychiat 2013 Sep–Oct;35(5):508–11.
32.Milsom, SR, Nair, SM, Ogilvie, CM, et al. Polycystic ovary syndrome and depression in New Zealand adolescents. J Pediat Adolesc Gynecol 2013 Jun;26(3):142–7.
33.Boomsma, CM, Eijkemans, MJ, Hughes, EG, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006 Nov–Dec;12(6):673–83.
34.Rai, R, Backos, M, Rushworth, F, Regan, L. Polycystic ovaries and recurrent miscarriage – a reappraisal. Hum Reprod 2000;15(3):612–15.
35.Grigorescu, V, Zhang, Y, Kissin, DM, et al. Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction. Fertil Steril 2014 Apr;101(4):1019–25.
36.Knowler, WC, et al. for the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 Feb 7;346(6):393–403.
37.Panidis, D, Tziomalos, K, Macut, D, et al. Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome. Gynecol Endocrinol 2013 Oct;29(10):926–30.
38.Vessey, M, Painter, R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004. Br J Cancer 2006;95:385–89.
39.Verit, FF. The prevalence of metabolic syndrome in clomiphene citrate resistant polycystic ovary syndrome. Gynecol Endocrinol 2012 May;28(5):365–9.
40.Creanga, AA, Bradly, HM, McCormick, C, Witkop, CT. Use of metformin in polycystic ovary syndrome. Obstet Gynecol 2008;111(4): 959–68.
41.Mathur, R, Alexander, CJ, Yano, J, et al. Use of metformin in polycystic ovary syndrome. Am Obstet Gynecol 2008 Dec;199(6): 596–609.
42.Nestler, JE, Jakubowicz, DJ, Evans, WS, Pasquali, R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. New Engl J Med 1998 Jun 25;338(26):1876–80.
43.Velazquez, E, Acosta, A, Mendoza, SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 1997 Sep;90(3):392–5.
44.Marshall, JC, Dunaif, A. Should all women with PCOS be treated for insulin resistance? Fertil Steril 2012 Jan;97(1):18–22.
45.Palomba, S, Falbo, A, Zullo, F, Orio, F. Evidence based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 2013 July;30(1):1–50.
46.Swiglo, BA, Cosma, M, Flynn, DN, et al. Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008 Apr;93(4):1153–60.
47.Pasquali, R, Gambineri, A. Glucose intolerance states in women with the polycystic ovary syndrome. [Review] J Endocrinol Invest 2013 Sep;36(8):648–53.
48.Lerchbaum, E, Schwetz, V, Giuliani, A, Obermayer-Pietsch, B. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method. Hum Reprod 2013 Sep;28(9):2537–44.